Integra culture vessel boosts MAb production
A new range of cell culture vessels developed by Switzerland's Integra Biosciences promises to increase production yields in laboratories making monoclonal antibodies and recombinant proteins.
A new range of cell culture vessels developed by Switzerland's Integra Biosciences promises to increase production yields in laboratories making monoclonal antibodies and recombinant proteins.
A deal with Vaccinex has taken Lonza Biologics beyond its primary focus of mammalian cell culture-based manufacturing and into the area of antibody drug discovery.
Merck KGaA has trimmed down its operations in France with the closure of a site at Lacassagne focusing on preclinical R&D and production.
A joint venture between UK inhaler specialist Profile and generics company Breath opens up a new market valued at $1 billion
Danish pharmaceutical companies increased their sales to overseas countries by 20 per cent in the first four months of this year compared with the same period of 2002, according to Invest In Denmark.